Inventor · disambiguated record
Brian Rabinovich
Also filed as: RABINOVICH BRIAN · RABINOVICH BRIAN A
7 granted patents·6 pending applications·66 citations·filing 2000–2024
83Inventor score
Files withIOVANCE BIOTHERAPEUTICS INC6UNIV TEXAS4FUSE BIOTHERAPEUTICS INC1MERCK PATENT GMBH1VASOGEN IRELAND LTD1
Top patents by PatentIndex Score
13 records- 0192US10415015B2Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansionIOVANCE BIOTHERAPEUTICS INC·Filed 2017·Granted Sep 17, 2019·19 cites·12 claims
- 0292US10125193B2Chimeric antigen receptors and methods of makingUNIV TEXAS·Filed 2015·Granted Nov 13, 2018·23 cites·7 claims
- 0385US11141434B2Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereofIOVANCE BIOTHERAPEUTICS INC·Filed 2017·Granted Oct 12, 2021·4 cites·27 claims
- 0484US6800300B1Method for treating autoimmune and alloimmune diseasesVASOGEN IRELAND LTD·Filed 2000·Granted Oct 5, 2004·20 cites·9 claims
- 0581US2025002579A1Chimeric antigen receptors and methods of makingUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0672US12065490B2Chimeric antigen receptors and methods of makingUNIV TEXAS·Filed 2021·Granted Aug 20, 2024·0 cites·20 claims
- 0769US2022315892A1Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte ExpansionIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0869US2022315893A1Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte ExpansionIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0967US12023355B2Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereofIOVANCE BIOTHERAPEUTICS INC·Filed 2021·Granted Jul 2, 2024·0 cites·22 claims
- 1063US11667890B2Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansionIOVANCE BIOTHERAPEUTICS INC·Filed 2019·Granted Jun 6, 2023·0 cites·12 claims
- 1160US2024343800A1Proteins that decouple t cell-mediated tumor cytotoxicity from release of pro-inflammatory cytokinesMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 1257US2025313627A1Receptor tyrosine kinase-like orphan receptor 1 (ror1)-specific vhh antibodies and multispecific antibodies thereof as immune cell engagersFUSE BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1357US2019085079A1Chimeric antigen receptors and methods of makingUNIV TEXAS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Rabinovich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →